Investing in Citizen Stash Cannabis Corp.

Growing your investment through cannabis.

A growing opportunity

Citizen Stash Cannabis Corp. (CSCC) is a Federally Licensed Cannabis company focused on distributing high quality cannabis products. With its state of the art facility, ability to source, process and distribute products nationally, is there opportunity? Plenty.

The underlying reason why investors originally invested in this sector remains the same: cannabis is and will continue to be a thriving multi-billion-dollar industry, with significant growth potential year over year.

There has never been a better time to invest in cannabis

  • Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024
  • The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025
  • Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025

Contact investor relations here, or view our investor presentation below.

Citizen Stash Advantages

Driving shareholder value through the distribution of quality cannabis products.

Best at Building Premium Brands
• One of the best known premium brands: Citizen Stash
• Created through proprietary IP & genetics
National Distribution
• Serving 7 provinces and territories
• Built the supply chain and network to support a
national brand
Proven Strategy and Performance
• Scale craft efficiently with co farming model
• Capital efficient supply and inventory
• 405% increase in Q1 2021 vs Q1 2020
• Adjusted positive EBITDA in Q1 2021
The Opportunity
• Highly scalable
• Operating in a growing market
• Significant growth opportunities
• Undervalued to peers

Public Filings

Find the most recent public filings from Citizen Stash Cannabis Corp. (formerly Experion Holdings Ltd.) on Sedar Financial News.

The Numbers

  • $5.2B

    Projected spend Adult-use cannabis in Canada by 2024 (USD)

  • $1.88B

    Potential size of the Medical marijuana market in Canada by 2025 (USD)

  • $2.03B

    Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)

  • $66.3B

    Global cannabis spend by the end of 2025 (USD)

THE KEY POINT

As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform

Stand for Something

Subscribe to our newsletter for updates
and curated content delivered to: